OBI Pharma, Inc. (TPEX:4174)
Taiwan · Delayed Price · Currency is TWD 37.95
+0.05 (0.13%)
Apr 17, 2026, 1:30 PM CST
OBI Pharma Market Cap
OBI Pharma has a market cap or net worth of 4.99 billion as of April 17, 2026. Its market cap has decreased by -66.80% in one year.
Market Cap
4.99B
Enterprise Value
5.16B
Revenue
58.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
37.95
Market Cap Chart
Since December 12, 2012, OBI Pharma's market cap has decreased from 16.87B to 4.99B, a decrease of -70.39%. That is a compound annual growth rate of -8.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 4.99B | -29.67% |
| Dec 31, 2025 | 7.10B | -53.86% |
| Dec 31, 2024 | 15.39B | -3.28% |
| Dec 29, 2023 | 15.91B | 0.50% |
| Dec 30, 2022 | 15.83B | -30.20% |
| Dec 30, 2021 | 22.68B | -13.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AnnJi Pharmaceutical | 5.79B |
| Steminent Biotherapeutics | 5.69B |
| Panion & Bf Biotech | 5.57B |
| UnicoCell Biomed | 5.15B |
| Senhwa Biosciences | 4.87B |
| Pharmosa Biopharm | 4.83B |
| Formosa Pharmaceuticals | 4.79B |
| Medigen Biotechnology | 4.37B |